<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR86">
 <label>86.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cobleigh</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>CL</given-names>
   </name>
   <name>
    <surname>Tripathy</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Robert</surname>
    <given-names>NJ</given-names>
   </name>
   <name>
    <surname>Scholl</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Fehrenbacher</surname>
    <given-names>L</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease</article-title>
  <source>J Clin Oncol</source>
  <year>1999</year>
  <volume>17</volume>
  <fpage>2639</fpage>
  <lpage>2648</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.1999.17.9.2639</pub-id>
  <?supplied-pmid 10561337?>
  <pub-id pub-id-type="pmid">10561337</pub-id>
 </element-citation>
</ref>
